ALPEX ACQUISITION CORP-CL A

ALPX · NASDAQ

Updated at 2026-10-15 08:21:23

$9.97+0.1%
Today's High
$9.97
Today’s Low
$9.97
ALPEX ACQUISITION CORP-CL A (ALPX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$9.97
Previous Close
$9.97
Volume
100.01K
Market Cap
$140.17M
P/E Ratio
--
EPS
--

Previous Day Range

$9.97$9.97

52-Week Range

$9.99$10.75

Company Overview

Sector
FINANCIAL SERVICES
Industry
N/A
Sub-industry
SHELL COMPANIES
Headquarters
300 DELAWARE AVE., WILMINGTON, DE, UNITED STATES, 19801
Country
US
Listing Date
2026-06-25
Fiscal Year End
December
Shares Outstanding
14.19M
CIK
0001880995
Website
--

Alopexx, Inc., a clinical stage biotechnology company, focusing on developing novel immune therapeutics for the prevention, treatment, and mitigation of bacterial, fungal, and parasitic infections. The company is headquartered in Cambridge, Massachusetts.

Financial Metrics

Revenue

2022-06-30

$0

2022-03-31

$0

2021-12-31

--

Operating Expenses

2022-06-30

$524.56K

2022-03-31

$491.32K

2021-12-31

--

Net Income

2022-06-30

-$539.76K

2022-03-31

-$500.22K

2021-12-31

--

Net Profit Margin

2022-06-30

--

2022-03-31

--

2021-12-31

--

Earnings Per Share

2022-06-30

--

2022-03-31

--

2021-12-31

--

Earnings Before Interest, Taxes, Depreciation, and Amortization

2022-06-30

-$524.56K

2022-03-31

-$491.32K

2021-12-31

--

Effective Tax Rate

2022-06-30

--

2022-03-31

--

2021-12-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.